As common chemotherapeutic drugs for HNSCC, they are also supposed to exhibit a similar synergistic effect with PD-1/PD-L1 blockade in HNSCC, but further clinical analysis still needs to be carried out. The gene discussed is PDCD1; the disease is head and neck squamous cell carcinoma.